Li-hui Wei - Gynecology

Author Information

Dr. Lihui Wei is affiliated with the Department of Obstetrics and Gynecology at Peking University People's Hospital, located at 11 Xizhimen South Street, Beijing 100044, China. Her work primarily focuses on gynecological and oncological research, contributing significantly to the understanding and treatment of various cancers, particularly those related to the human papillomavirus (HPV) and colorectal cancer.

Research Contributions

Dr. Lihui Wei has made substantial contributions to the field of gynecology and oncology. Her research has explored various aspects of cancer treatment and prevention, including the effectiveness of the quadrivalent human papillomavirus vaccine, the mechanisms of traditional Chinese medicine in treating colorectal cancer, and immune-related signatures in liver cancer. Additionally, she has investigated therapeutic DNA vaccines against HPV-related malignancies and the role of specific proteins in the progression of triple-negative breast cancer. Her work is characterized by its diversity, spanning from clinical trials to the molecular mechanisms underlying cancer progression and treatment.

Aliases

Dr. Lihui Wei is also known by the aliases Li-hui Wei and Lihui Wei.

Publication and Citation Metrics

Metric	Value
Total Citations	3570
H-Index	34
Total Publications	221

Publications:

The eight-year long-term follow-up on the effectiveness of the quadrivalent human papillomavirus vaccine in Chinese women 20-45 years of age.

DOI: 10.1080/21645515.2022.2052700

Year: 2022

Based on the Network Pharmacology to Investigate the Mechanism of Qingjie Fuzheng Granules against Colorectal Cancer

DOI: 10.1155/2022/7242640

Year: 2022

Immune‐related lncRNA signature delineates an immune‐excluded subtype of liver cancer with unfavorable clinical outcomes

DOI: 10.1002/jcla.24244

Year: 2022

Therapeutic DNA Vaccines against HPV-Related Malignancies: Promising Leads from Clinical Trials

DOI: 10.3390/v14020239

Year: 2022

Ribosome assembly factor PNO1 is associated with progression and promotes tumorigenesis in triple‑negative breast cancer.

DOI: 10.3892/or.2022.8319

Year: 2022

Naturally Acquired Antibodies Against Human Papillomavirus are Protective Against Subsequent Homotypic Infection: A Large-Scale Prospective Cohort Study

DOI: 10.2139/SSRN.3777238

Year: 2021

Qingda Granule Attenuates Angiotensin II-Induced Renal Apoptosis and Activation of the p53 Pathway

DOI: 10.3389/fphar.2021.770863

Year: 2021

Elimination of Cervical Cancer: Challenges Promoting the HPV Vaccine in China

DOI: 10.1007/s40944-021-00536-6

Year: 2021

Effect of Babao Dan on angiogenesis of gastric cancer in vitro by regulating VEGFA/VEGFR2 signaling pathway

DOI: 10.21037/tcr-20-2559

Year: 2021

Targeting NUFIP1 Suppresses Growth and Induces Senescence of Colorectal Cancer Cells

DOI: 10.3389/fonc.2021.681425

Year: 2021

What Should You Expect After the Procedure?

How is the management of polycystic ovary syndrome (PCOS) improving?

When are IV Pain Medications Used in Gynecology?

What is the Role of Estrone in Hormone Replacement Therapy (HRT)?

Why Are These Courses Important?

What is a Kidney Infection?

How to Write Effective Endnotes?

How Can Maternal Health Affect Fetal Development?

What Should Gynecologists Consider for Retirement Planning?

How Can Menopausal Women Be Affected?

Partnered Content Networks

Relevant Topics